Enzyme-linked immunosorbent assays using virus-like particles containing mutations of conserved residues on envelope protein can distinguish three flavivirus infections

References

• Lessler J, Chaisson LH, Kucirka LM, et al. Assessing the global threat from Zika virus. Science. 2016;353:aaf8160. doi: 10.1126/science.aaf8160
   PubMed Web of Science ®Google Scholar
• Musso D, Ko AI, Baud D. Zika virus infection – after the pandemic. N Engl J Med. 2019;381:1444–1457. doi: 10.1056/NEJMra1808246
   PubMed Web of Science ®Google Scholar
• Guidance for US Laboratories testing for Zika virus infection. From CDC’s website: http://www.cdc.gov/zika/laboratories/lab-guidance.html.
   Google Scholar
• Pierson TC, Diamond MS. Flaviviruses In: Knipe DM, Howley PM, editors. Fields virology. Philadelphia: Lippincott William & Wilkins; 2013. p. 747–794.
   Google Scholar
• Martin DA, Muth DA, Brown T, et al. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol. 2000;38:1823–1826. doi: 10.1128/JCM.38.5.1823-1826.2000
   PubMed Web of Science ®Google Scholar
• Johnson AJ, Martin DA, Karabatsos N, et al. Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay. J Clin Microbiol. 2000;38:1827–1831. doi: 10.1128/JCM.38.5.1827-1831.2000
   PubMed Web of Science ®Google Scholar
• Modis Y, Ogata S, Clements D, et al. Structure of the dengue virus envelope protein after membrane fusion. Nature. 2004;427:313–319. doi: 10.1038/nature02165
   PubMed Web of Science ®Google Scholar
• Lai CY, Tsai WY, Lin SR, et al. Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. J Virol. 2008;82:6631–6643. doi: 10.1128/JVI.00316-08
   PubMed Web of Science ®Google Scholar
• Crill WD, Hughes HR, Delorey MJ, et al. Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens. PLoS One. 2009;4:e4991. doi: 10.1371/journal.pone.0004991
   PubMed Web of Science ®Google Scholar
• Lai CY, Williams KL, Wu YC, et al. Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases. PLoS Negl Trop Dis. 2013;7:e2451. doi: 10.1371/journal.pntd.0002451
   PubMed Web of Science ®Google Scholar
• Tsai WY, Lai CY, Wu YC, et al. High avidity and potent neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection. J Virol. 2013;87:12562–12575. doi: 10.1128/JVI.00871-13
   PubMed Web of Science ®Google Scholar
• Lanciotti RS, Kosoy OL, Laven JJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis. 2008;14:1232–1239. doi: 10.3201/eid1408.080287
   PubMed Web of Science ®Google Scholar
• Johnson BW, Kosoy O, Martin DA, et al. West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses. Vector Borne Zoonotic Dis. 2005;5:137–145. doi: 10.1089/vbz.2005.5.137
   PubMed Web of Science ®Google Scholar
• van Meer MPA, Mögling R, Klaasse J, et al. Re-evaluation of routine dengue virus serology in travelers in the era of Zika virus emergence. J Clin Virol. 2017;92:25–31. doi: 10.1016/j.jcv.2017.05.001
   PubMed Web of Science ®Google Scholar
• Felix AC, Souza NCS, Figueiredo WM, et al. Cross reactivity of commercial anti-dengue immunoassays in patients with acute Zika virus infection. J Med Virol. 2017;89:1477–1479. doi: 10.1002/jmv.24789
   PubMed Web of Science ®Google Scholar
• Ferlenghi I, Clarke M, Ruttan T, et al. Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus. Mol Cell. 2001;7:593–602. doi: 10.1016/S1097-2765(01)00206-4
   PubMed Web of Science ®Google Scholar
• Schalich J, Allison SL, Stiasny K, et al. Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions. J Virol. 1996;70:4549–4557. doi: 10.1128/JVI.70.7.4549-4557.1996
   PubMed Web of Science ®Google Scholar
• Lorenz IC, Kartenbeck J, Mezzacasa A, et al. Intracellular assembly and secretion of recombinant subviral particles from tick-borne encephalitis virus. J Virol. 2003;77:4370–4382. doi: 10.1128/JVI.77.7.4370-4382.2003
   PubMed Web of Science ®Google Scholar
• Davis BS, Chang GJ, Cropp B, et al. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. J Virol. 2001;75:4040–4047. doi: 10.1128/JVI.75.9.4040-4047.2001
   PubMed Web of Science ®Google Scholar
• Chiou SS, Crill WD, Chen LK, et al. Enzyme-linked immunosorbent assays using novel Japanese encephalitis virus antigen improve the accuracy of clinical diagnosis of flavivirus infections. Clin Vaccine Immunol. 2008;15:825–835. doi: 10.1128/CVI.00004-08
   PubMedGoogle Scholar
• Roberson JA, Crill WD, Chang GJ. Differentiation of West Nile and St. Louis encephalitis virus infections by use of noninfectious virus-like particles with reduced cross-reactivity. J Clin Microbiol. 2007;45:3167–3174. doi: 10.1128/JCM.01143-07
   PubMed Web of Science ®Google Scholar
• de Alwis R, Smith SA, Olivarez NP, et al. Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. Proc Natl Acad Sci USA. 2012;109:7439–7444. doi: 10.1073/pnas.1200566109
   PubMed Web of Science ®Google Scholar
• Fibriansah G, Tan JL, Smith SA, et al. A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface. EMBO Mol Med. 2014;6:358–371. doi: 10.1002/emmm.201303404
   PubMed Web of Science ®Google Scholar
• Dejnirattisai W, Wongwiwat W, Supasa S, et al. A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat Immunol. 2015;16:170–177. doi: 10.1038/ni.3058
   PubMed Web of Science ®Google Scholar
• Teoh EP, Kukkaro PP, Teo EW, et al. The structural basis for serotype-specific neutralization of dengue virus by a human antibody. Sci Transl Med. 2012;4:139ra83. doi: 10.1126/scitranslmed.3003888
   PubMed Web of Science ®Google Scholar
• Steinhagen K, Probst C, Radzimski C, et al. Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016. Euro Surveill. 2016;21:30426. doi: 10.2807/1560-7917.ES.2016.21.50.30426
   PubMedGoogle Scholar
• Lustig Y, Zelena H, Venturi G, et al. Sensitivity and kinetics of an NS1-based Zika virus enzyme-linked immunosorbent assay in Zika virus-infected travelers from Israel, the Czech Republic, Italy, Belgium, Germany, and Chile. J Clin Microbiol. 2017;55:1894–1901. doi: 10.1128/JCM.00346-17
   PubMed Web of Science ®Google Scholar
• Safronetz D, Sloan A, Stein DR, et al. Evaluation of 5 commercially available Zika virus immunoassays. Emerg Infect Dis. 2017;23:1577–1580. doi: 10.3201/eid2309.162043
   PubMed Web of Science ®Google Scholar
• Balmaseda A, Zambrana JV, Collado D, et al. Comparison of four serological methods and two reverse transcription-PCR assays for diagnosis and surveillance of Zika virus infection. J Clin Microbiol. 2018;56:e01785–17. doi: 10.1128/JCM.01785-17
   PubMed Web of Science ®Google Scholar
• Tsai WY, Youn HH, Brites C, et al. Distinguishing secondary dengue virus infection from Zika virus infection with previous dengue by combination of three simple serological tests. Clin Infect Dis. 2017;65:1829–1836. doi: 10.1093/cid/cix672
   PubMed Web of Science ®Google Scholar
• Tyson J, Tsai WY, Tsai JJ, et al. Combination of non-structural protein 1-based enzyme-linked immunosorbent assays can detect and distinguish various dengue virus and Zika virus infections. J Clin Microbiol. 2019;57:e01464–18.
   PubMed Web of Science ®Google Scholar
• Tyson J, Tsai WY, Tsai JJ, et al. A high-throughput and multiplex microsphere immunoassay based on non-structural protein 1 can discriminate three flavivirus infections. PLoS Negl Trop Dis. 2019;13:e0007649. doi: 10.1371/journal.pntd.0007649
   PubMed Web of Science ®Google Scholar
• Premkumar L, Collins M, Graham S, et al. Development of envelope protein antigens to serologically differentiate Zika virus infection from dengue virus infection. J Clin Microbiol. 2018;56:e01504–17.
   PubMed Web of Science ®Google Scholar
• Chao DY, Whitney MT, Davis BS, et al. Comprehensive evaluation of differential serodiagnosis between Zika and dengue viral infections. J Clin Microbiol. 2019;57:e01506–18.
   PubMed Web of Science ®Google Scholar
• Chabierski S, Barzon L, Papa A, et al. Distinguishing West Nile virus infection using a recombinant envelope protein with mutations in the conserved fusion-loop. BMC Infect Dis. 2014;14:246. doi: 10.1186/1471-2334-14-246
   PubMed Web of Science ®Google Scholar
• Rockstroh A, Barzon L, Pacenti M, et al. Recombinant envelope-proteins with mutations in the conserved fusion loop allow specific serological diagnosis of dengue-infections. PLoS Negl Trop Dis. 2015;9:e0004218. doi: 10.1371/journal.pntd.0004218
   PubMed Web of Science ®Google Scholar
• Rockstroh A, Moges B, Barzon L, et al. Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop. Emerg Microbes Infect. 2017;6:e99. doi: 10.1038/emi.2017.87
   PubMed Web of Science ®Google Scholar
• Dejnirattisai W, Supasa P, Wongwiwat W, et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat Immunol. 2016;17:1102–1108. doi: 10.1038/ni.3515
   PubMed Web of Science ®Google Scholar
• Priyamvada L, Quicke KM, Hudson WH, et al. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc Natl Acad Sci U S A. 2016;113:7852–7857. doi: 10.1073/pnas.1607931113
   PubMed Web of Science ®Google Scholar
• Bardina SV, Bunduc P, Tripathi S, et al. Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science. 2017;356:175–180. doi: 10.1126/science.aal4365
   PubMed Web of Science ®Google Scholar
• Rathore APS, Saron WAA, Lim T, et al. Maternal immunity and antibodies to dengue virus promote infection and Zika virus-induced microcephaly in fetuses. Sci Adv. 2019;5:eaav3208. doi: 10.1126/sciadv.aav3208
   PubMed Web of Science ®Google Scholar
• McCracken MK, Gromowski GD, Friberg HL, et al. Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques. PLoS Pathog. 2017;13:e1006487. doi: 10.1371/journal.ppat.1006487
   PubMed Web of Science ®Google Scholar
• Pantoja P, Pérez-Guzmán EX, Rodríguez IV, et al. Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus. Nat Commun. 2017;8:15674. doi: 10.1038/ncomms15674
   PubMed Web of Science ®Google Scholar
• Halstead SB. Biologic evidence required for Zika disease enhancement by dengue antibodies. Emerg Infect Dis. 2017;23:569–573. doi: 10.3201/eid2304.161879
   PubMed Web of Science ®Google Scholar
• Gordon A, Gresh L, Ojeda S, et al. Prior dengue virus infection and risk of Zika: A pediatric cohort in Nicaragua. PLoS Med. 2019;16:e1002726. doi: 10.1371/journal.pmed.1002726
   PubMed Web of Science ®Google Scholar
• Rodriguez-Barraquer I, Costa F, Nascimento EJM, et al. Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region. Science. 2019;363:607–610. doi: 10.1126/science.aav6618
   PubMed Web of Science ®Google Scholar
• Kuan G, Gordon A, Avilés W, et al. The Nicaraguan pediatric dengue cohort study: study design, methods, use of information technology, and extension to other infectious diseases. Am J Epidemiol. 2009;170:120–129. doi: 10.1093/aje/kwp092
   PubMed Web of Science ®Google Scholar
• Narvaez F, Gutierrez G, Perez MA, et al. Evaluation of the traditional and revised WHO classifications of dengue disease severity. PLoS Negl Trop Dis. 2011;5:e1397. doi: 10.1371/journal.pntd.0001397
   PubMed Web of Science ®Google Scholar
• Stramer SL, Fang CT, Foster GA, et al. West Nile virus among blood donors in the United States, 2003 and 2004. N Engl J Med. 2005;353:451–459. doi: 10.1056/NEJMoa044333
   PubMed Web of Science ®Google Scholar
• Wang WK, Chen HL, Yang CF, et al. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin Infect Dis. 2006;43:1023–1030. doi: 10.1086/507635
   PubMed Web of Science ®Google Scholar
• Tsai WY, Chen HL, Tsai JJ, et al. Potent neutralizing human monoclonal antibodies preferentially target mature dengue virus particles: implication for novel strategy of dengue vaccine. J Virol. 2018;92:e00556–18.
   PubMed Web of Science ®Google Scholar
• Tsai JJ, Liu CK, Tsai WY, et al. Seroprevalence of dengue in two districts of Kaohsiung city after the largest dengue outbreak in Taiwan since world war II. PLoS Negl Trop Dis. 2018;12:e0006879. doi: 10.1371/journal.pntd.0006879
   PubMed Web of Science ®Google Scholar
• Klock HE, Lesley SA. The polymerase incomplete primer extension (PIPE) method applied to high-throughput cloning and site-directed mutagenesis. Methods Mol Biol. 2009;498:91–103. doi: 10.1007/978-1-59745-196-3_6
   PubMedGoogle Scholar
• Frey A, Di Canzio J, Zurakowski D. A statistically defined endpoint titer determination method for immunoassays. J Immunol Methods. 1998;221:35–41. doi: 10.1016/S0022-1759(98)00170-7
   PubMed Web of Science ®Google Scholar
• Dowd KA, DeMaso CR, Pelc RS, et al. Broadly neutralizing activity of Zika virus-immune sera identifies a single viral serotype. Cell Rep. 2016;16:1485–1491. doi: 10.1016/j.celrep.2016.07.049
   PubMed Web of Science ®Google Scholar
• Montoya M, Collins M, Dejnirattisai W, et al. Longitudinal analysis of antibody cross-neutralization following Zika virus and dengue virus infection in Asia and the Americas. J Infect Dis. 2018;218:536–545. doi: 10.1093/infdis/jiy164
   PubMed Web of Science ®Google Scholar
• Munoz-Jordan JL. Diagnosis of Zika virus infections: challenges and opportunities. J Infect Dis. 2017;216(Suppl. 10):S951–S956. doi: 10.1093/infdis/jix502
   PubMed Web of Science ®Google Scholar
• Simmons G, Stone M, Busch MP. Arbovirus diagnostics: from bad to worse due to expanding dengue virus vaccination and Zika virus epidemics. Clin Infect Dis. 2018;66:1181–1183. doi: 10.1093/cid/cix972
   PubMed Web of Science ®Google Scholar